Personalized medicine support system : resolving conflict in allocation to risk groups and predicting patient molecular response to targeted therapy
Files
(Published version)
Date
2017
Authors
Banjar, H.
Adelson, D.
Brown, F.
Leclercq, T.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Health Informatics - An International Journal, 2017; 6(2):1-21
Statement of Responsibility
Haneen Banjar, David Adelson, Fred Brown, and Tamara Leclercq
Conference Name
Abstract
Treatment management in cancer patients is largely based on the use of a standardized set of predictive and prognostic factors. The former are used to evaluate specific clinical interventions, and they can be useful for selecting treatments because they directly predict the response to a treatment. The latter are used to evaluate a patient’s overall outcomes, and can be used to identify the risks or recurrence of a disease. Current intelligent systems can be a solution for transferring advancements in molecular biology into practice, especially for predicting the molecular response to molecular targeted therapy and the prognosis of risk groups in cancer medicine. This framework primarily focuses on the importance of integrating domain knowledge in predictive and prognostic models for personalized treatment. Our personalized medicine support system provides the needed support in complex decisions and can be incorporated into a treatment guide for selecting molecular targeted therapies.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Health Informatics - An International Journal, 2017; 6(2):1-21AIRCC Journal papers published under the Creative Commons Attribution (CC BY) license.